China retaliates in growing trade war

The tit-for-tat trade skirmish between America and China intensified this week with Beijing announcing its own set of tariffs.

890-China-634

China's Ministry of Commerce responded with new tariffs on US goods (pictured is spokesman Gao Feng at a press conference)
(Image credit: 2018 China News Service)

The tit-for-tat trade skirmish between America and China intensified this week. China's Ministry of Commerce first announced tariffs on imports of US products worth a total of $3bn, in response to US tariffs on Chinese metals last month. The US responded with plans for 25% tariffs on a wide range of Chinese imports worth around $50bn. China then announced further tariffs on a narrower range of goods mostly agriculture products worth a similar amount.

The risks of a trade war are clearly rising and "all equities are vulnerable", says Alex Newman in the Investors Chronicle. The more globalised and interconnected markets and economies have become, "the greater the potential blowback from the chaotic application of new tariffs. Retaliatory measures can hit any company, and any sector, wiping out margins and supply chains in the process." This is clear from the EU's threat to impose levies on Jack Daniel's whisky and Harley-Davidson motorcycles in response to US steel tariffs.

The most vulnerable equities, however, are in emerging markets. Many developing countries are geared plays on global trade and growth, with Asia especially dependent on exports. Damage to regional heavyweight China's economy would dent global demand for commodities, which bodes ill for key exporters such as Australia and Indonesia.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

It would also undermine momentum around the region; one estimate suggests that a 1% fall in China's GDP growth would lower Asia's growth by at least 0.3%. One key problem, as Joyce Poon points out in a Gavekal Research note, is that many "intermediate" or unfinished goods are sent to China from elsewhere in Asia for final assembly before being sent on to the US. However, most intermediate goods shipped to China are used for products sold domestically, which limits the "collateral damage" from US tariffs.

Fundamentals are solid

Provided a trade war can be avoided, there should be more mileage in emerging markets. Earnings, which are closely correlated to exports, are recovering after six years of stagnation, thanks to strengthening global growth and firmer commodity prices. Macroeconomic management has also improved in recent years, with several emerging markets reducing debt and taming inflation. They have also tended to borrow in their own currency and issue longer-date bonds in the latest cycle, making their economies less vulnerable to a falling currency.

Given the global mood, developing countries that are relatively insulated from the global economy and boast large domestic markets could do better than key exporters for now. Two of our favourites that fit the bill are Brazil and India.

Andrew Van Sickle

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.